Pacer Advisors
RLAY icon

Pacer Advisors’s Relay Therapeutics RLAY Stock Holding History

Pacer Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,103
Closed -$7.19K – 2673
2024
Q2 		$7.19K Sell
1,103
-1,054
-49% -$7.2K ﹤0.01% 3597
2024
Q1 		$17.9K Buy
+2,157
New +$21K ﹤0.01% 3464
2021
Q2 		– Sell
-1,981
Closed -$68K – 1535
2021
Q1 		$68K Buy
1,981
+432
+28% +$18.7K ﹤0.01% 1390
2020
Q4 		$64K Buy
+1,549
New +$70K ﹤0.01% 1399

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Pacer Advisors's RLAY Position: Q3 2024 in Review

Pacer Advisors sold out of Relay Therapeutics (RLAY) in Q3 2024, closing a stake of 1,103 shares — an estimated $7.19K sold.

Pacer Advisors first reported a position in RLAY in Q4 2020 and held it in 4 quarters. The position peaked at $68K in Q1 2021. 195 funds tracked by Wall St. Rank hold RLAY as of Q3 2024.

  • Pacer Advisors reported no remaining Relay Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,103 Relay Therapeutics shares in Q3 2024, an estimated $7.19K.
  • Pacer Advisors first reported a position in Relay Therapeutics in Q4 2020 and held it in 4 quarters.
  • Pacer Advisors's Relay Therapeutics position peaked at $68K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.